Whilst stimulant-involved overdose deaths continue to climb across developed nations, a groundbreaking study has revealed that a relatively simple treatment approach could be saving thousands of lives if only it were widely available.

New research published in the American Journal of Psychiatry shows that contingency management treatment (a behavioural intervention that rewards people for meeting recovery milestones) reduced the risk of death by 41% amongst veterans with stimulant use disorder. That’s not a marginal improvement. That’s a life-saving intervention hiding in plain sight.

What Is Contingency Management Treatment?

Contingency management (CM) might sound complicated, but the concept is straightforward: reward positive behaviour to encourage more of it.

When someone with substance use disorder provides a negative drug test or participates in treatment activities, they receive tangible rewards like gift cards, vouchers, or social recognition. It’s based on a fundamental principle of human psychology: positive reinforcement works.

Previous research has consistently found contingency management to be effective in treating substance use disorders, with lower dropout rates and improved treatment outcomes. But this new study goes further. It proves that contingency management treatment doesn’t just help people stay in treatment. It keeps them alive.

The Study That Changes Everything

Researchers analysed records from nearly 3,000 veterans diagnosed with stimulant use disorder who received care through the Veterans Health Administration (VHA), the largest integrated healthcare system in the United States.

The findings were unequivocal. Participants who received contingency management were 41% less likely to die within one year compared to similar patients who didn’t receive the intervention. This remained true even after accounting for hospitalisations, co-occurring mental health conditions, and housing instability.

The magnitude of benefit was comparable to that seen with medications for opioid use disorder, such as buprenorphine. That’s extraordinary, particularly because there are currently no FDA-approved medications for treating stimulant use disorder.

For conditions where pharmaceutical options don’t exist, contingency management treatment offers a proven, evidence-based alternative that actually saves lives.

Why Stimulant Use Disorder Needs Urgent Attention

Stimulant-related deaths have been rising sharply. Methamphetamine and cocaine overdoses, often combined with opioids, have become increasingly common. Yet treatment options remain limited.

Unlike opioid use disorder, where medications like methadone and buprenorphine have transformed outcomes, stimulant use disorder has largely been left without pharmacological solutions. This makes behavioural interventions like contingency management treatment even more critical.

The current crisis demands innovative approaches. When traditional medication isn’t available, we need to deploy every evidence-based tool we have, and CM is one of the most effective tools in the box.

The Treatment Gap That’s Costing Lives

Here’s what’s maddening: we have a treatment that works, backed by rigorous research, proven to reduce mortality by 41%, and most people who need it can’t access it.

Contingency management treatment remains underutilised in both public and private health systems. Despite decades of evidence supporting its effectiveness, implementation has been frustratingly slow.

Why? Partly due to misconceptions about “rewarding” people with substance use disorders. Some view incentive-based treatment as controversial or inappropriate. But this perspective ignores the evidence and, frankly, costs lives.

The VHA’s successful implementation demonstrates that large-scale adoption is possible. If the largest integrated healthcare system in the United States can do it, community health centres and private providers can too.

How Contingency Management Treatment Actually Works

The mechanics are simple but the impact is profound:

Set clear, achievable goals: Negative drug tests, attendance at counselling sessions, participation in treatment activities.

Provide immediate rewards: Gift cards, vouchers, or other tangible incentives when goals are met.

Build momentum: As individuals experience success, confidence grows and recovery becomes more sustainable.

The approach works because it provides immediate, positive feedback in a person’s recovery journey, something that traditional treatment models often lack. Instead of focusing solely on consequences of drug use, contingency management treatment emphasises rewards for positive change.

Research by Dutra and colleagues found that CM participants had lower dropout rates and better treatment outcomes compared to standard care. The current study adds the most important outcome of all: they’re more likely to stay alive.

Why This Matters for Substance Use Disorder Prevention

Effective treatment is prevention. When people with substance use disorders can access evidence-based interventions like contingency management treatment, they’re less likely to overdose, less likely to engage in high-risk behaviours, and more likely to maintain long-term recovery.

But prevention also means ensuring these treatments are available before people reach crisis point. Expanding access to CM could help interrupt the trajectory from occasional use to dependence to overdose.

The study’s findings are particularly relevant given rising rates of stimulant use amongst young people. As substance-related deaths surge in the 15-24 age group, having proven interventions available becomes even more urgent.

What Needs to Happen Now

The evidence is overwhelming. Contingency management treatment saves lives. So why isn’t it standard practice everywhere?

Expand implementation beyond the VHA: Community health centres, addiction treatment facilities, and private providers must adopt CM programmes.

Remove regulatory and funding barriers: Many insurance systems don’t adequately cover contingency management treatment, creating access gaps.

Train healthcare providers: Clinicians need education on how to implement CM effectively and dispel misconceptions about incentive-based treatment.

Increase public awareness: People struggling with substance use disorders and their families need to know this option exists.

Invest in research: Continue studying optimal implementation strategies and long-term outcomes.

The authors of the study note that expanding access to contingency management in both public and private health systems could help close the treatment gap and improve survival outcomes for people affected by stimulant use. That’s not a suggestion. It’s an imperative.

A Treatment That Works If We Use It

We don’t often get clear-cut evidence in healthcare. Treatment effects are usually modest, confounded by multiple variables, difficult to measure. But a 41% reduction in mortality? That’s unambiguous.

Contingency management treatment works. It’s cost-effective, evidence-based, and proven to save lives. The only question is whether we have the political will and institutional courage to implement it widely.

Thousands of people die each year from stimulant-involved overdoses. Many of those deaths are preventable with access to effective treatment like CM. Every day we delay expanding access is another day people die unnecessarily.

The solution exists. The evidence is clear. Now we need to act.

Source: Addiction Policy